AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
5.58
-0.16 (-2.79%)
Aug 28, 2026, 4:00 PM EDT - Market closed
AN2 Therapeutics Employees
AN2 Therapeutics had 21 employees as of December 31, 2025. The number of employees decreased by 1 or -4.55% compared to the previous year.
Employees
21
Change (1Y)
-1
Growth (1Y)
-4.55%
Revenue / Employee
n/a
Profits / Employee
-$1,727,429
Market Cap
210.57M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | -1 | -4.55% | 21 | 0 |
| Dec 31, 2024 | 22 | -19 | -46.34% | 22 | 0 |
| Dec 31, 2023 | 41 | 5 | 13.89% | 41 | 0 |
| Mar 31, 2023 | 36 | 14 | 63.64% | 35 | 1 |
| Dec 31, 2022 | 36 | 14 | 63.64% | 35 | 1 |
| Sep 30, 2022 | 27 | 5 | 22.73% | 26 | 1 |
| Jun 30, 2022 | 25 | - | - | 25 | 0 |
| Mar 31, 2022 | 22 | - | - | 22 | 0 |
| Dec 31, 2021 | 22 | - | - | 22 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Innate Pharma | 164 |
| Coherus Oncology | 144 |
| Voyager Therapeutics | 141 |
| Immunic | 100 |
| Precision BioSciences | 67 |
| Acumen Pharmaceuticals | 61 |
| PepGen | 57 |
ANTX News
- 6 days ago - AN2 Therapeutics appoints Trenor as Chief Medical Officer - TheFly
- 6 days ago - AN2 Therapeutics Appoints Cameron Trenor, M.D., as Chief Medical Officer - Business Wire
- 18 days ago - AN2 Therapeutics reports Q2 EPS (18c), two estimates (24c) - TheFly
- 18 days ago - AN2 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business and Scientific Highlights - Business Wire
- 18 days ago - AN2 Therapeutics Earnings release: Q2 2026 - Filings
- 18 days ago - AN2 Therapeutics Quarterly report: Q2 2026 - Filings
- 5 weeks ago - AN2 Therapeutics initiated with a Buy at Guggenheim - TheFly
- 5 weeks ago - AN2 Therapeutics initiated with a Buy at Guggenheim - TheFly